Tag: Recombinant Erythropoietin Drugs Market

Recombinant Erythropoietin Drugs Market Trends And Drivers The Recombinant Erythropoietin Drugs Market was valued at USD 10.72 Billion in 2022 and is projected to reach USD 16.32 Billion by 2030, growing at a CAGR of 5.3% from 2024 to 2030. The increasing prevalence of chronic kidney diseases (CKD), anemia, and cancer-related treatments has been a […]